Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial

Mahfoud F, Bloch MJ, Azizi M, Wang Y, Schmieder R, Lobo MD, Sharp ASP, Daemen J, Basile J, Weber MA, Scicli AP, Mcclure CK, Kirtane AJ (2021)

Publication Type: Journal article

Publication year: 2021

Journal

EuroIntervention Europa Group

Book Volume: 17

Pages Range: E1024-+

Journal Issue: 12

DOI: 10.4244/EIJ-D-21-00295

Abstract

Background: The multicentre, randomised, sham-controlled RADIANCE-HTN SOLO trial reported the blood pressure (BP)-lowering efficacy and safety of ultrasound renal denervation (RDN) in the absence (2 months) and presence (6 and 12 months) of antihypertensive medications in patients with mild-to-moderate hypertension.

Authors with CRIS profile

Roland Schmieder Professur für Innere Medizin (Nephrologie)

Involved external institutions

Universitätsklinikum des Saarlandes (UKS)

Germany (DE) University of Nevada Las Vegas

United States (USA) (US) University of Paris 4 - Paris-Sorbonne / Université paris IV Paris-Sorbonne

France (FR) Abbott Northwestern Hospital

United States (USA) (US) Queen Mary University of London

United Kingdom (GB) Cardiff and Vale University Health Board

United Kingdom (GB) Erasmus University Medical Center (MC)

Netherlands (NL) Medical University of South Carolina (MUSC)

United States (USA) (US) SUNY Downstate Medical Center

United States (USA) (US) ReCor Medical Inc.

United States (USA) (US) North American Science Associates (NAMSA)

United States (USA) (US) Columbia University

United States (USA) (US)

How to cite

APA:

Mahfoud, F., Bloch, M.J., Azizi, M., Wang, Y., Schmieder, R., Lobo, M.D.,... Kirtane, A.J. (2021). Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial. EuroIntervention, 17(12), E1024-+. https://doi.org/10.4244/EIJ-D-21-00295

MLA:

Mahfoud, Felix, et al. "Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial." EuroIntervention 17.12 (2021): E1024-+.

BibTeX: Download